Transient severe thrombocytopenia in a patient on CAPD after intravenous iron administration [4]
dc.authorscopusid | 6701745769 | |
dc.authorscopusid | 6602896819 | |
dc.authorscopusid | 6506553303 | |
dc.authorscopusid | 57535532500 | |
dc.authorscopusid | 7004568106 | |
dc.authorscopusid | 56264100700 | |
dc.contributor.author | Taskapan H. | |
dc.contributor.author | Bahceci F. | |
dc.contributor.author | Taskapan C. | |
dc.contributor.author | Sahin I. | |
dc.contributor.author | Kaya E. | |
dc.contributor.author | Aydogdu I. | |
dc.date.accessioned | 2024-08-04T19:59:33Z | |
dc.date.available | 2024-08-04T19:59:33Z | |
dc.date.issued | 2003 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.endpage | 409 | en_US |
dc.identifier.issn | 0896-8608 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 12968855 | en_US |
dc.identifier.scopus | 2-s2.0-0042420696 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 408 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/90718 | |
dc.identifier.volume | 23 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Peritoneal Dialysis International | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | amlodipine | en_US |
dc.subject | calcium carbonate | en_US |
dc.subject | iron | en_US |
dc.subject | recombinant erythropoietin | en_US |
dc.subject | adult | en_US |
dc.subject | case report | en_US |
dc.subject | chronic kidney failure | en_US |
dc.subject | continuous ambulatory peritoneal dialysis | en_US |
dc.subject | disease severity | en_US |
dc.subject | dose response | en_US |
dc.subject | fatigue | en_US |
dc.subject | female | en_US |
dc.subject | hemodialysis patient | en_US |
dc.subject | human | en_US |
dc.subject | hypertension | en_US |
dc.subject | iron deficiency anemia | en_US |
dc.subject | laboratory test | en_US |
dc.subject | letter | en_US |
dc.subject | priority journal | en_US |
dc.subject | tablet formulation | en_US |
dc.subject | thrombocyte count | en_US |
dc.subject | thrombocytopenia | en_US |
dc.subject | thrombocytosis | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | vitamin supplementation | en_US |
dc.subject | Adult | en_US |
dc.subject | Anemia, Iron-Deficiency | en_US |
dc.subject | Erythropoietin | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Infusions, Intravenous | en_US |
dc.subject | Iron | en_US |
dc.subject | Kidney Failure, Chronic | en_US |
dc.subject | Peritoneal Dialysis, Continuous Ambulatory | en_US |
dc.subject | Thrombocytopenia | en_US |
dc.title | Transient severe thrombocytopenia in a patient on CAPD after intravenous iron administration [4] | en_US |
dc.type | Letter | en_US |